TY - JOUR
T1 - Bioimpedance Spectroscopy for Assessment of Breast Cancer-Related Lymphedema
T2 - A Systematic Review
AU - Forte, Antonio J.
AU - Huayllani, Maria T.
AU - Boczar, Daniel
AU - Ciudad, Pedro
AU - Lu, Xiaona
AU - Kassis, Salam
AU - Parker, Alexander S.
AU - Moore, Pamela A.
AU - McLaughlin, Sarah A.
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Bioimpedance spectroscopy is currently used to evaluate patients with breast cancer-related lymphedema (BCRL). We aimed to describe published studies on the use of bioimpedance spectroscopy for assessment for BCRL. We queried the PubMed, Ovid Medline, and Embase databases to identify studies that evaluated the use of bioimpedance spectroscopy as an assessment tool. We searched for the keywords "bioimpedance" AND ("lymphedema" OR "lymphoedema"). We included English-language studies that reported the use of bioimpedance spectroscopy for assessment of BCRL. Out of 152, 116, and 235 articles identified in each database, respectively, only a total of 11 articles were included. Bioimpedance spectroscopy was studied as a method to assess and predict response to BCRL treatment, assess volume changes, and calibrate L-Dex scores for conversion to units of volume. All studies reported that bioimpedance spectroscopy is a promising tool for predicting response to BCRL treatment and measuring volume changes. Bioimpedance spectroscopy can be used for assessment of BCRL. However, the accuracy of bioimpedance spectroscopy for BCRL assessment has not been determined, and consequently further studies are needed.
AB - Bioimpedance spectroscopy is currently used to evaluate patients with breast cancer-related lymphedema (BCRL). We aimed to describe published studies on the use of bioimpedance spectroscopy for assessment for BCRL. We queried the PubMed, Ovid Medline, and Embase databases to identify studies that evaluated the use of bioimpedance spectroscopy as an assessment tool. We searched for the keywords "bioimpedance" AND ("lymphedema" OR "lymphoedema"). We included English-language studies that reported the use of bioimpedance spectroscopy for assessment of BCRL. Out of 152, 116, and 235 articles identified in each database, respectively, only a total of 11 articles were included. Bioimpedance spectroscopy was studied as a method to assess and predict response to BCRL treatment, assess volume changes, and calibrate L-Dex scores for conversion to units of volume. All studies reported that bioimpedance spectroscopy is a promising tool for predicting response to BCRL treatment and measuring volume changes. Bioimpedance spectroscopy can be used for assessment of BCRL. However, the accuracy of bioimpedance spectroscopy for BCRL assessment has not been determined, and consequently further studies are needed.
UR - http://www.scopus.com/inward/record.url?scp=85085538870&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085538870&partnerID=8YFLogxK
U2 - 10.1097/PSN.0000000000000306
DO - 10.1097/PSN.0000000000000306
M3 - Article
C2 - 32459756
AN - SCOPUS:85085538870
VL - 40
SP - 86
EP - 90
JO - Plastic Surgical Nursing
JF - Plastic Surgical Nursing
SN - 0741-5206
IS - 2
ER -